(Total Views: 482)
Posted On: 05/06/2025 10:37:43 AM
Post# of 154593
Quote:
With ESMO on everyone’s brain you might find the presentation slide deck from the December 2022 investor call of interest
The best result in any patient at 12 months was displayed where carboplatin had been discontinued during the trial period and only leronlimab was used.
(19)
(0)
